Gapping up
In reaction to earnings/guidance:
- WDFC +9.1%, PSFE +4.7% (reaffirms guidance for Q1 and FY22; also names new CEO), UMC +2.2%, DBI +2.2%, QDEL +1.6%, TSM +0.8%, PSMT +0.7%, .
Other news:
- GATO +5.6% (names new CEO; also announces record quarterly production)
- CRWD +3.8% (secures Provisional Authorization to Operate at Impact Level 4; says it expects to achieve $5 bln in annual recurring revenue)
- WOW +3.7% (co is exploring options including a sale according to Bloomberg)
- IIPR +2.8% (announces quarterly operating activity)
- MNOV +2.4% (announces secondary analysis of Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Alcoholism: Clinical and Experimental Research)
- WAL +1.7% (extends contract for CEO)
- TRQ +1.7% (provides update on review of acquisition proposal RIO)
- SAVE +1.6% (to begin discussions with JetBlue Airways)
- GRPN +1.5% (10% owner (Pale Fire's Jan Barta) affirms increased holding and 7.8% active stake)
- JBLU +1.3% (Spirit Airlines to begin discussions with JetBlue Airways)
- BHP +1.1% (provides update on BHP Petroleum and Woodside merger and share distribution information)
Analyst comments:
- CPNG +2.5% (upgraded to Conviction Buy from Buy at Goldman)
- ITT +2.2% (upgraded to Buy from Neutral at UBS)
- APPF +2% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- CHRW +1.2% (upgraded to Overweight from Neutral at JP Morgan)